Free Trial

Nyxoah (NYXH) Competitors

Nyxoah logo
$8.01 +0.08 (+0.95%)
As of 01:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NYXH vs. LQDA, SSII, PLSE, INMD, MDXG, KMTS, SIBN, IRMD, CBLL, and EMBC

Should you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Liquidia Technologies (LQDA), SS Innovations International (SSII), Pulse Biosciences (PLSE), InMode (INMD), MiMedx Group (MDXG), Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), and Embecta (EMBC). These companies are all part of the "medical equipment" industry.

Nyxoah vs. Its Competitors

Nyxoah (NASDAQ:NYXH) and Liquidia Technologies (NASDAQ:LQDA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

Nyxoah currently has a consensus target price of $14.50, suggesting a potential upside of 81.14%. Liquidia Technologies has a consensus target price of $26.89, suggesting a potential upside of 86.15%. Given Liquidia Technologies' higher probable upside, analysts plainly believe Liquidia Technologies is more favorable than Nyxoah.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Liquidia Technologies
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00

Nyxoah has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, Liquidia Technologies has a beta of -0.01, meaning that its share price is 101% less volatile than the S&P 500.

64.5% of Liquidia Technologies shares are held by institutional investors. 30.1% of Liquidia Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Liquidia Technologies had 19 more articles in the media than Nyxoah. MarketBeat recorded 20 mentions for Liquidia Technologies and 1 mentions for Nyxoah. Nyxoah's average media sentiment score of 1.89 beat Liquidia Technologies' score of 0.21 indicating that Nyxoah is being referred to more favorably in the media.

Company Overall Sentiment
Nyxoah Very Positive
Liquidia Technologies Neutral

Liquidia Technologies has a net margin of -903.80% compared to Nyxoah's net margin of -1,571.39%. Nyxoah's return on equity of -63.37% beat Liquidia Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Nyxoah-1,571.39% -63.37% -46.67%
Liquidia Technologies -903.80%-177.91%-60.15%

Nyxoah has higher earnings, but lower revenue than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyxoah$4.89M55.76-$64.10M-$2.13-3.76
Liquidia Technologies$14.14M87.30-$130.39M-$1.58-9.14

Summary

Liquidia Technologies beats Nyxoah on 10 of the 16 factors compared between the two stocks.

Get Nyxoah News Delivered to You Automatically

Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NYXH vs. The Competition

MetricNyxoahMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$272.65M$1.98B$5.56B$9.30B
Dividend YieldN/AN/A4.23%4.03%
P/E Ratio-3.7634.1528.6119.64
Price / Sales55.7614.98437.49188.30
Price / CashN/A54.7436.0257.93
Price / Book2.228.558.185.63
Net Income-$64.10M-$62.39M$3.23B$257.73M
7 Day Performance3.29%-2.01%-0.25%0.07%
1 Month Performance3.29%10.04%5.40%8.32%
1 Year Performance-14.84%3.57%26.35%13.78%

Nyxoah Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NYXH
Nyxoah
2.8516 of 5 stars
$8.01
+0.9%
$14.50
+81.1%
-14.7%$272.65M$4.89M-3.76110
LQDA
Liquidia Technologies
3.1968 of 5 stars
$12.45
+2.1%
$26.89
+116.0%
+16.6%$1.04B$14M-7.8850Trending News
Insider Trade
SSII
SS Innovations International
N/A$5.27
-1.3%
N/AN/A$1.03B$20.65M0.004
PLSE
Pulse Biosciences
3.715 of 5 stars
$15.81
+3.3%
$22.00
+39.2%
-22.0%$1.03B$700K0.00140
INMD
InMode
4.0614 of 5 stars
$15.10
-0.4%
$18.54
+22.8%
-20.1%$958.25M$394.82M6.48480News Coverage
Positive News
MDXG
MiMedx Group
3.6738 of 5 stars
$6.48
+2.2%
$12.50
+92.9%
-11.2%$936.43M$348.88M24.00870News Coverage
Analyst Forecast
KMTS
Kestra Medical Technologies
N/A$14.75
-5.9%
$27.50
+86.4%
N/A$804.64M$52.64M0.00300News Coverage
SIBN
SiBone
3.9739 of 5 stars
$18.01
-2.5%
$22.50
+24.9%
+8.6%$787.09M$167.18M-28.14350Positive News
IRMD
iRadimed
4.7046 of 5 stars
$59.02
-4.5%
$72.00
+22.0%
+25.8%$785.79M$73.24M38.08110
CBLL
CeriBell
2.6065 of 5 stars
$17.20
-9.1%
$32.14
+86.9%
N/A$684.19M$65.44M0.00N/A
EMBC
Embecta
4.7497 of 5 stars
$10.03
-2.8%
$19.33
+92.8%
-25.4%$603.13M$1.08B11.142,100News Coverage
Positive News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:NYXH) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners